{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T02:10:01Z","timestamp":1739153401168,"version":"3.37.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1007\/bf03042673","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T02:10:34Z","timestamp":1244513434000},"page":"585-591","source":"Crossref","is-referenced-by-count":2,"title":["Verminderte Inzidenz von Nebenwirkungen einer Wachstumshormonsubstitution bei 404 Patienten mit Hypophyseninsuffizienz","Reduced incidence of side effects by growth hormone substitution in 404 patients with pituitary insufficiency. Results of a multicenter surveillance program"],"prefix":"10.1007","volume":"93","author":[{"name":"Deutsche KIMS-Studiengruppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"W\u00fcster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Melchinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Eversmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Hensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"von zur M\u00fchlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Ranke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Schmeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Steinkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Tuschy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03042673_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2265.1996.d01-1552.x","volume":"45","author":"KA Shoumer Al","year":"1996","unstructured":"Al Shoumer KA, Ali K, Anyaoku V, et al. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clin Endocrinol (Oxf). 1996;45: 171\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03042673_CR2","first-page":"19","volume-title":"Lipid metabolism disorders and coronary heart disease","author":"G Assmann","year":"1993","unstructured":"Assmann G, Schulte H Results and conclusions of the Prospective Cardiovascular M\u00fcnster (PROCAM) study. In: Assmann G, ed. Lipid metabolism disorders and coronary heart disease. M\u00fcnchen: MMV Medizin Verlag, 1993:19\u201368."},{"key":"BF03042673_CR3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1530\/acta.0.1240620","volume":"124","author":"P Bang","year":"1991","unstructured":"Bang P, Eriksson U, Sara V, et al. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 1991;124:620\u20139.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF03042673_CR4","first-page":"1169","volume":"81","author":"AS Bates","year":"1996","unstructured":"Bates AS, van Hoff W, Jones PJ, et al. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996;81:1169\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR5","first-page":"309","volume":"76","author":"B\u00c5 Bengtsson","year":"1993","unstructured":"Bengtsson B\u00c5, Ed\u00e9n S, Lonn L. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 1993;76:309\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/ajcn\/61.6.1186","volume":"61","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Freemantle C, Thomas E, et al. Comparison of measurements of body composition by total body potassium, bioimpedance analysis, and dual-energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. Am J Clin Nutr 1995;61:1186\u201394.","journal-title":"Am J Clin Nutr"},{"key":"BF03042673_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","volume":"42","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Freemantle C, Thomas E Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 1995;42:179\u201389.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03042673_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1300451","volume":"130","author":"SA Beshyah","year":"1994","unstructured":"Beshyah SA, Shahi M, Skinner E, et al. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol 1994;130:451\u20138.","journal-title":"Eur J Endocrinol"},{"key":"BF03042673_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/joe.0.1490007","volume":"149","author":"S Boonen","year":"1996","unstructured":"Boonen S, Aerssens J, Dequeker J. Age-related endocrine deficiencies and fractures of the proximal femur. 1. Implications of growth-hormone deficiency in the elderly. J Endocrinol 1996;149:7\u201312.","journal-title":"J Endocrinol"},{"key":"BF03042673_CR10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2265.1994.tb01832.x","volume":"41","author":"KM Bradly","year":"1994","unstructured":"Bradly KM, Adams CB, Potter CP, et al. An audit of elected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocrinol (Oxf) 1994;41:655\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03042673_CR11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","volume":"46","author":"B B\u00fclow","year":"1997","unstructured":"B\u00fclow B, Hagmar L, Mikoczy Z, et al. Increased cerebrovascular mortality in patients with hypopituitarism Clin Endocrinol (Oxf) 1997;46:75\u201381.","journal-title":"Endocrinol (Oxf)"},{"key":"BF03042673_CR12","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/jcem.80.12.8530603","volume":"80","author":"P Burman","year":"1995","unstructured":"Burman P, Broman JE, Hetta J. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995;80:3585\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","volume":"70","author":"RC Cuneo","year":"1991","unstructured":"Cuneo RC, Salomon F, Wiles CM, et al. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 1991;70: 695\u2013700.","journal-title":"J Appl Physiol"},{"key":"BF03042673_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","volume":"16","author":"H Boer de","year":"1995","unstructured":"de Boer H, Blok GJ, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrinol Rev 1995;16:63\u201386.","journal-title":"Endocrinol Rev"},{"key":"BF03042673_CR15","first-page":"420","volume":"4","author":"LC Doward","year":"1995","unstructured":"Doward LC. The development of the AGHDA: a measure to assess quality of life of adults with growth hormone deficiency. Quality Life Res 1995;4:420\u20131.","journal-title":"Quality Life Res"},{"key":"BF03042673_CR16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","volume":"42","author":"J Fowelin","year":"1993","unstructured":"Fowelin J, Attvall S, Lager I, et al. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993;42:1443\u20137.","journal-title":"Metabolism"},{"key":"BF03042673_CR17","first-page":"72","volume":"80","author":"DM Hoffman","year":"1995","unstructured":"Hoffman DM, O\u2019Sullivan AJ, Freund J, et al. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995;80:72\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR18","first-page":"63","volume":"2","author":"SJ Holmes","year":"1995","unstructured":"Holmes SJ, McKenna SP, Doward LC, et al. Development of a questionnaire to access the quality of life of adults with growth hormone deficiency. Endocrinol Metab 1995;2:63\u20139.","journal-title":"Endocrinol Metab"},{"key":"BF03042673_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000184836","volume":"45","author":"SJ Holmes","year":"1996","unstructured":"Holmes SJ, Shalet SM. Adult growth hormone deficiency and bone mass. Horm Res 1996;45:69\u201371.","journal-title":"Horm Res"},{"key":"BF03042673_CR20","first-page":"129","volume":"82","author":"YJH Janssen","year":"1997","unstructured":"Janssen YJH, Fr\u00f6lich M, Roelfsema F. A low starting dose of Genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab 1997;82:129\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR21","first-page":"727","volume":"82","author":"G Johannsson","year":"1997","unstructured":"Johannsson G, M\u00e5rin P, L\u00f8nn L. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997;82:727\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR22","first-page":"3","volume":"3","author":"G Johannsson","year":"1996","unstructured":"Johannsson G, Ros\u00e9n T, Lindstedt G, et al. Effect of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. Endocrinol Metab 1996;3:3\u201312.","journal-title":"Endocrinol Metab"},{"key":"BF03042673_CR23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","volume":"14","author":"JO Johansson","year":"1994","unstructured":"Johansson JO, Landin K, Tengborn L, et al. High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 1994;14:434\u20137.","journal-title":"Arterioscler Thromb"},{"key":"BF03042673_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000126813","volume":"61","author":"JO Johansson","year":"1995","unstructured":"Johansson JO, Larson G, Anderson M. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995;61:57\u201366.","journal-title":"Neuroendocrinology"},{"key":"BF03042673_CR25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","volume":"1","author":"JO J\u00f8rgensen","year":"1989","unstructured":"J\u00f8rgensen JO, Pedersen SA, Thuesen L. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;1:1221\u20135.","journal-title":"Lancet"},{"key":"BF03042673_CR26","first-page":"281","volume":"3","author":"JO J\u00f8rgensen","year":"1996","unstructured":"J\u00f8rgensen JO, Vahl N, Nyholm B. Substrate metabolism and insulin sensitivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults. Endocrinol Metab 1996;3:281\u20136.","journal-title":"Endocrinol Metab"},{"key":"BF03042673_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/edrv-12-3-235","volume":"2","author":"PA Kelly","year":"1991","unstructured":"Kelly PA, Djiane J, Postel Vinay MC, et al. The prolactin\/growth hormone receptor family. Endocrinol Rev 1991;2:235\u201351.","journal-title":"Endocrinol Rev"},{"issue":"Suppl A","key":"BF03042673_CR28","first-page":"43","volume":"1","author":"G M\u00e5rdh","year":"1994","unstructured":"M\u00e5rdh G, Lundin K, Berg G, et al. Growth Hormone Replacement Therapy in Adult Hypopituitary Patients with Growth Hormone Deficiency: Combined Data from 12 European Placebo-Controlled Clinical Trials. Endocrinol Metabol 1994;1:Suppl A:43\u20139.","journal-title":"Endocrinol Metabol"},{"key":"BF03042673_CR29","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","volume":"340","author":"V Markussis","year":"1992","unstructured":"Markussis V, Beshyah SA, Fisher C, et al. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992;340:1188\u201392.","journal-title":"Lancet"},{"key":"BF03042673_CR30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2265.1993.tb02386.x","volume":"39","author":"J M\u00f6ller","year":"1993","unstructured":"M\u00f6ller J, J\u00f8rgensen JO, Lauersen T. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) 1993;39:403\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03042673_CR31","first-page":"552","volume":"80","author":"R Nass","year":"1995","unstructured":"Nass R, Huber RM, Klauss V, et al. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 1995;80:552\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Ros\u00e9n","year":"1990","unstructured":"Ros\u00e9n T, Bengtsson B\u00c5. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336:285\u20138.","journal-title":"Lancet"},{"key":"BF03042673_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","volume":"40","author":"T Ros\u00e9n","year":"1994","unstructured":"Ros\u00e9n T, Wir\u00e9n L, Wilhelmsen L, et al. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 1994;40:111\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03042673_CR34","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","volume":"321","author":"F Salomon","year":"1989","unstructured":"Salomon F, Cuneo RC, Hesp R, et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797\u2013803.","journal-title":"N Engl J Med"},{"key":"BF03042673_CR35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1055\/s-2008-1047701","volume":"122","author":"C Strasburger","year":"1997","unstructured":"Strasburger C, Kann P, Oertel H, et al. Diagnostische Kriterien f\u00fcr die Indikation zur Wachstumshormon-Substitution bei Erwachsenen. Dtsch Med Wochenschr 1997; 122:861\u20133.","journal-title":"Dtsch Med Wochenschr"},{"key":"BF03042673_CR36","first-page":"115","volume":"41","author":"The Principal Investigators of the MONICA Project","year":"1988","unstructured":"The Principal Investigators of the MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35\u201364 years. Wld Hlth Statist Quart 1988;41:115\u201340.","journal-title":"Wld Hlth Statist Quart"},{"key":"BF03042673_CR37","doi-asserted-by":"crossref","unstructured":"Verhelst J, Abs R, Vandeweghe M. Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) (in press).","DOI":"10.1046\/j.1365-2265.1997.3041112.x"},{"key":"BF03042673_CR38","first-page":"153","volume":"80","author":"JU Weaver","year":"1995","unstructured":"Weaver JU, Monson JP, Noonan K. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 1995;80:153\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03042673_CR39","unstructured":"Wir\u00e9n L, Willhelmsen L, McKenna S, et al. A comparison of the quality of life of growth hormone deficient adult and a random sample population in Sweden. 22nd Int. Sympos on Growth Hormone and Growth Factors in Endocrinology and Metabolism, Vienna, October 1996."},{"key":"BF03042673_CR40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF01797616","volume":"69","author":"C W\u00fcster","year":"1991","unstructured":"W\u00fcster C, Slenczka E, Ziegler R. Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: is there a need for additional growth hormone substitution? Klin Wochenschr 1991;69:769\u201373.","journal-title":"Klin Wochenschr"},{"key":"BF03042673_CR41","first-page":"3","volume":"2","author":"C W\u00fcster","year":"1995","unstructured":"W\u00fcster C. Growth hormone, insulin-like growth factors and bone metabolism. Endocrinol Metab 1995;2:3\u201312.","journal-title":"Endocrinol Metab"},{"key":"BF03042673_CR42","first-page":"A2402","volume":"91","author":"C W\u00fcster","year":"1994","unstructured":"W\u00fcster C, von zur M\u00fchlen A, Ranke M. Das Syndrom des Wachstumshormonmangels beim Erwachsenen. Dtsch \u00e9rztebl 1994;91:A2402\u20138.","journal-title":"Dtsch \u00e9rztebl"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03042673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03042673\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03042673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T01:35:18Z","timestamp":1739151318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03042673"}},"subtitle":["Ergebnisse einer Multicenteranwendungsbeobachtung"],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["BF03042673"],"URL":"https:\/\/doi.org\/10.1007\/bf03042673","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"type":"print","value":"0723-5003"},{"type":"electronic","value":"1615-6722"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}